CEO Alain Moussy Expounds on the Complex Journey of Masitinib Development in Interview| Alain Moussy, CEO, AB Science SA. 00:10:00
In this interview, CEO Alain Moussy provides comprehensive insights into the intricate development process of Masitinib, shedding light on the challenges, breakthroughs, and future prospects of this innovative pharmaceutical endeavor